New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH

February 23rd, 2023 Media Contact: Elizabeth Mortek Inprela Elizabeth@inprela.com 612.677.2025 New AASLD Practice Guidance Calls for the Use of Noninvasive Liver Evaluations for Earlier Detection of NAFLD and NASH Screening with FibroScan® (VCTE™ technology) is recommended for individuals at high risk for NAFLD and NASH PARIS and Waltham, MA –...